Zyprexa is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Pd-rx Pharmaceuticals, Inc.. The primary component is Olanzapine.
Product ID | 55289-213_7bd524e6-2b5c-6377-e053-2a91aa0a2814 |
NDC | 55289-213 |
Product Type | Human Prescription Drug |
Proprietary Name | Zyprexa |
Generic Name | Olanzapine |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 1996-10-01 |
Marketing Category | NDA / NDA |
Application Number | NDA020592 |
Labeler Name | PD-Rx Pharmaceuticals, Inc. |
Substance Name | OLANZAPINE |
Active Ingredient Strength | 10 mg/1 |
Pharm Classes | Atypical Antipsychotic [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2011-06-21 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020592 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2011-06-21 |
Marketing End Date | 2019-09-11 |
Ingredient | Strength |
---|---|
OLANZAPINE | 10 mg/1 |
SPL SET ID: | 7c6ff491-c30c-4ada-85a0-cbee98f2fe32 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0002-4112 | Zyprexa | Olanzapine |
0002-4115 | Zyprexa | Olanzapine |
0002-4116 | Zyprexa | Olanzapine |
0002-4117 | Zyprexa | Olanzapine |
0002-4415 | Zyprexa | Olanzapine |
0002-4420 | Zyprexa | Olanzapine |
0002-4453 | ZYPREXA | Olanzapine |
0002-4454 | ZYPREXA | Olanzapine |
0002-4455 | ZYPREXA | Olanzapine |
68258-7092 | Zyprexa | Zyprexa |
68258-7093 | Zyprexa | Zyprexa |
68258-7090 | Zyprexa | Zyprexa |
68258-7091 | Zyprexa | Zyprexa |
70518-1465 | Zyprexa | Zyprexa |
21695-144 | Zyprexa | Zyprexa |
21695-140 | Zyprexa | Zyprexa |
21695-142 | Zyprexa | Zyprexa |
49999-606 | Zyprexa | Zyprexa |
52959-579 | Zyprexa | Zyprexa |
55289-213 | Zyprexa | Zyprexa |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ZYPREXA 75078626 2072867 Live/Registered |
Eli Lilly and Company 1996-03-26 |